Categories: Multiple Sclerosis

10/16/2017

UCSF offers cautious recap but equates surrogate markers with clinical outcomes in MS drug study

2/7/2017

NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations

8/15/2016

Do statistically insignificant outcomes in multiple sclerosis treatment study deserve a news release?

1 6/20/2016

Ottawa Hospital release on MS therapy hits the right notes with clarity and cautions

4/19/2016

Data absent from claim that video game benefits MS patients

12/13/2015

Engaging UCLA release suggests pregnancy hormone may benefit MS patients – but lacks key data

1 4/27/2015

Exaggeration at the NIH? Mouse study release may go too far in suggesting “reversal” of multiple sclerosis

News Release Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on TwitterHealthNewsReview.org Retweeted
Kidfears99Laura Marston@Kidfears99·

A great read on this weekend’s NYT claims of a cure for Type 1.

Cure for Type 1 diabetes? We’ve been down this road before with NY Times https://www.healthnewsreview.org/2021/11/cure-for-type-1-diabetes-weve-been-down-this-road-before-with-ny-times/

Reply on Twitter 1465416998746308611Retweet on Twitter 146541699874630861118Like on Twitter 146541699874630861151Twitter 1465416998746308611
Retweet on TwitterHealthNewsReview.org Retweeted
chrishendelChris Hendel@chrishendel·

"But it is the framing and the emphasis of the #journalism by a leading science journalist at a leading newspaper that demands scrutiny. It has an impact on readers and on sick people that may cause harm by promoting false hope about extremely preliminary research"

👍👏💪 truth https://twitter.com/garyschwitzer/status/1465399358137024518

Reply on Twitter 1465403458618634241Retweet on Twitter 14654034586186342412Like on Twitter 14654034586186342417Twitter 1465403458618634241
View More

Categories

View More

Tags